498 participants
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-28
- Start Date:
- 2020-07-29
- Completion:
- 2027-12-31
Conditions
- Non-Small Cell Lung Cancer
- Colorectal Cancer
- Advanced Solid Tumors
Interventions
- DRUG
No Results Yet